Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Skagen Trial 1, Moderately Hypofractionated Loco-regional Adjuvant Radiation Therapy of Early Breast Cancer Combined With a Simultaneous Integrated Boost: a Randomised Clinically Controlled Trial

NCT02384733 is registered in ClinicalTrials.gov with Danish Breast Cancer Cooperative Group as lead sponsor.

NCT NCT02384733
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02384733 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Skagen Trial 1, Moderately Hypofractionated Loco-regional Adjuvant Radiation Therapy of Early Breast Cancer Combined With a Simultaneous Integrated Boost: a Randomised Clinically Controlled Trial
Lead sponsor
Danish Breast Cancer Cooperative Group
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 31, 2015
Completion date
July 1, 2032
Enrollment
2,963 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fibrosis, lymphedema